Skip to main content

FDA Updates

FDA Updates

Pembrolizumab Approved for Patients with Head and Neck Cancer

FDA Updates

Monthly Injection Approved for Patients with Relapsed Multiple Sclerosis

FDA Updates

Netspot Approved for Detection of Neuroendocrine Tumors

FDA Updates

First EGFR Mutation Blood Test Approved for Patients with NSCLC

FDA Updates

Atezolizumab Approved for Patients with Advanced or Metastatic Urothelial Carcinoma

FDA Updates

Nivolumab Approved for Patients with Relapsed, Refractory Classical Hodgkin Lymphoma

FDA Updates

Lenvatinib Approved for Use with Everolimus for Treating Advanced Renal Cell Carcinoma

FDA Updates

Venclexta FDA Approved for Patients with CLL

FDA Updates

FDA Approves Defitelio for Patients with Rare Disorder After HSCT

FDA Updates

FDA Enhances Warnings for Serious Risks of Opioid Analgesics Abuse

7
8
9
10
11
12
13

Page 10 of 13
Results 91 - 100 of 123